The overall objective of this proposal is to improve the diagnosis, treatment and rehabilitation of children with cancer through participation in protocols designed by Children's Cancer Study Group. Specifically, we plan to enter eligible patients on CCSG protocols, participate in development of protocols, participate in doing biologic studies and supplying biologic materials, serve as a referral center for patients requiring bone marrow transplantation and do independent research studies which may serve as a background for group wide studies in the future. The Children's Hospital Medical Center is the major pediatric center within a 50-75 mile radius of Cincinnati and is the only pediatric unit within Cincinnati. There are four other pediatric centers that are affiliates of CHMC: University of Kentucky, Akron Children's Hospital, Hershey Medical Center and Scottish Rite Hospital in Atlanta. CHMC and the affiliates have a multidisciplinary approach to the evaluation and treatment of cancer in children and are one of the largest contributors of patients on CCSG protocols. Personnel from CHMC and the affiliates are contributing heavily to the scientific endeavors of CCSG by participating through Strategy Groups and Committees which are studying Acute Non-Lymphocytic Leukemia, Relapsed Acute Lymphocytic Leukemia, Non-Hodgkin's Lymphoma, Neuroblastoma, Wilm's Tumor, Brain Tumors, Bone Tumors and Bone Marrow Transplantation. The Bone Marrow Transplant Unit at CHMC is one of the largest, oldest and most active of the units participating in CCSG studies. The capacity of this unit will be expanded further during the next five years both in physical space and in personnel. CHMC is also helping to advance biologic studies of CCSG by banking solid tumors from CCSG institutions by freezing tissue and injecting tumor tissue in nude mice. This tissue will be available for research studies as determined by the Biology Committee of CCSG. Certainly investigators at CHMC will be one of the CCSG institutions using this material for cytogenetic and molecular genetic studies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA026126-15
Application #
3556807
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1979-07-01
Project End
1993-11-30
Budget Start
1992-12-01
Budget End
1993-11-30
Support Year
15
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Neudorf, Steven; Sanders, Jean; Kobrinsky, Nathan et al. (2004) Allogeneic bone marrow transplantation for children with acute myelocytic leukemia in first remission demonstrates a role for graft versus leukemia in the maintenance of disease-free survival. Blood 103:3655-61
Shamberger, Robert C; LaQuaglia, Michael P; Gebhardt, Mark C et al. (2003) Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Ann Surg 238:563-7; discussion 567-8
Casillas, Jacqueline N; Woods, William G; Hunger, Stephen P et al. (2003) Prognostic implications of t(10;11) translocations in childhood acute myelogenous leukemia: a report from the Children's Cancer Group. J Pediatr Hematol Oncol 25:594-600
Davies, Stella M; Bhatia, Smita; Ross, Julie A et al. (2002) Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia. Blood 100:67-71
Wells, Robert J; Reid, Joel M; Ames, Matthew M et al. (2002) Phase I trial of cisplatin and topotecan in children with recurrent solid tumors: Children's Cancer Group Study 0942. J Pediatr Hematol Oncol 24:89-93
Lange, Beverly J; Bostrom, Bruce C; Cherlow, Joel M et al. (2002) Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 99:825-33
Ou, Shu Xiao; Han, Dehui; Severson, Richard K et al. (2002) Birth characteristics, maternal reproductive history, hormone use during pregnancy, and risk of childhood acute lymphocytic leukemia by immunophenotype (United States). Cancer Causes Control 13:15-25
Cairo, M S; Krailo, M D; Morse, M et al. (2002) Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ('Orange') in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report. Leukemia 16:594-600
Wells, R J; Arthur, D C; Srivastava, A et al. (2002) Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213. Leukemia 16:601-7
Arndt, C A; Krailo, M D; Liu-Mares, W et al. (2001) Phase I study of CI-958 in children and adolescents with recurrent solid tumors. Cancer 91:1166-9

Showing the most recent 10 out of 17 publications